Skip to content
  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Brasil
  • Central de Atendimento +55 11 2500 1570 WhatsApp +55 11 9 7117 9759
  • PORTAL DE CLÍNICAS
  • Solicitar informação
  • Central de Atendimento +55 11 2500 1570 WhatsApp +55 11 9 7117 9759
  • Part of brands: |
Igenomix BrasilIgenomix Brasil
  • Part of brands: |
  • Patient Journey
    • Before Pregnant
    • IVF Process
    • Healthy pregnancy
    • After birth
  • SAÚDE REPRODUTIVA
  • SAÚDE GENÉTICA
  • Sobre nós
  • EVENTOS
  • Blog
PGT-SR Pacientes

PGT-SR Preimplantation Genetic Testing for Structural Rearrangements

Our most advanced test designed for couples where one or both of the partners carries a known balanced structural rearrangement in their chromosomes

  • Overview
  • Features
  • How does it Work?
  • I’m a health specialist

Custom and validated in-house NGS technology

Proprietary Artificial
Intelligence algorithm

Detection of chromosomal imbalances        ≥ 6MB with 98% accuracy

Overview

What is PGT-SR?

  • The Preimplantation genetic testing for Structural Rearrangements (PGT-SR), is a test performed on embryo biopsies to screen embryos for chromosomal imbalances (extra or missing chromosome material) resulting from a parental structural rearrangement.
  • In addition to screening for imbalances resulting from a parental structural rearrangement, PGT-SR also detects numerical chromosome abnormalities (aneuploidies). PGT-SR would be able to detect all of the same chromosome imbalances that would be assessed by PGT-A.

What is a Balanced Structural Rearrangement?

  • A balanced structural rearrangement, such as translocation or inversion, involves a change in chromosome structure without gains or losses in chromosome material.​
  • A translocation is a type of chromosomal rearrangement that occurs when genetic material is exchanged between two chromosomes. An inversion occurs when a chromosome segment is flipped within the chromosome.
  • Typically, a balanced structural rearrangement does not cause health concerns in carriers. However, a carrier of a balanced rearrangement has a higher risk of producing embryos with an unbalanced structural rearrangement (gain and/or loss of chromosome segments), which may lead to infertility, failed implantation, pregnancy loss, or the birth of a child with developmental delays and multiple congenital anomalies.
  • ​Children who inherit the balanced structural rearrangement from their carrier parent are not expected to have health concerns. ​
  • PGT-SR increases the probability of selecting a chromosomally normal (without the parental chromosomal rearrangement) or balanced (with the same parental chromosomal rearrangement) embryo for transfer, thus leading to improved assisted reproduction techniques (ART) outcomes. 
Features
  • Benefits
  • Indications
  • PGT-SR Plus

Main benefits:

PGT-SR significantly reduces the likelihood of transferring an embryo with an unbalanced structural rearrangement, and therefore:

    • Increases pregnancy rates per transfer:
      Selecting chromosomally normal embryos can increase the rate of pregnancy after transfer.
    • Reduces miscarriage rate:
      The risk for chromosomal abnormalities in embryos is higher when one partner carries a balanced structural rearrangement. The risk for miscarriage is reduced if a euploid embryo is transferred.
    • Increases the likelihood of having a healthy baby:
      Depending on the size of the resulting imbalances and the chromosomes involved, the presence of an unbalanced structural rearrangement could result in a baby with varying degrees of intellectual disability/birth defects.
    • Reduces the time and use of resources:
      Increases the chances for successful transfer by selecting embryos with the highest reproductive potential, reducing the time and costs of extra transfer cycles.

Who should consider PGT-SR?

PGT-SR is indicated for any couple in which one member has been identified to carry a balanced structural rearrangement, such as a:

  • Reciprocal translocation
  • Inversion
  • Robertsonian translocation

The presence of a structural rearrangement increases the risk of creating embryos with chromosomal imbalances.

PGT-SR may be indicated when other structural abnormalities, such as ring chromosomes, are identified in the patient. Evaluation of the karyotype by Igenomix is required.

PGT-SR Plus is our most advanced 4-in-1 genetic test that incorporates both NGS and SNP analysis to increase accuracy and confidence for embryo transfer. In addition to screening for imbalances detected by PGT-SR, PGT-SR Plus includes the following features:

Ploidy assessment:

PGT-SR Plus enables the detection of both haploidy and triploidy, ensuring the selection of embryos with the correct chromosome content.

In addition, PGT-SR Plus increases the number of viable euploid embryos available for transfer by detection true 2PN (diploid) embryos from 0PN, 1PN and 2.1/3PN embryos that may not otherwise be considered for transfer.

Cohort Check – Sibling QC:

Provides assurance that the tested embryos within a cohort are genetically related to each other.

Contamination:

Our testing process includes measures to detect both external cell DNA and maternal cell contamination increasing the accuracy and confidence of the testing process and significantly reducing the risk of misdiagnosis.

How does it work?
  • In order to determine whether PGT-SR can be offered, Igenomix will need to review the karyotype confirming the specific rearrangement that a member of the couple carries. The ordering provider should submit the karyotype report to Igenomix for PGT-SR case review.
  • In rare cases, Igenomix may need to perform a preliminary analysis, to confirm PGT-SR is feasible. A DNA sample from the partner who carries the structural rearrangement would be required.
  • Once Igenomix has completed the case review and confirmed that PGT-SR can be offered, embryo biopsy samples can be sent to Igenomix for PGT-SR analysis. Probe development is not required.
  • Screening for sporadic aneuploidies is also performed to identify embryos with numerical chromosome aneuploidies not associated with the parental chromosomal rearrangement. Since general aneuploidy screening is included, separate PGT-A testing is not required.
  • The MitoScore test can also be performed to identify embryos that could have a greater capacity for implantation

Other services

PGT-A Plus

PGT-A Igenomix

Our most advanced 4-in-1 genetic test offers increased accuracy and confidence for embryo transfer

A new enhanced version of our PGT-A test that now also includes features such as Ploidy analysis, Genetic PN check, contamination and sibling quality control.

More information

EMBRACE

Embryo Analysis of Culture Environment

EMBRACE is a new non-invasive test that helps you and your doctor identify the best-quality embryos to prioritize for transfer during your treatment cycle, which significantly increases the chance of a successful pregnancy.

More information

Infertility Panel

Identifying the genetic causes of infertility.

An advanced genetic test designed to detect the most common genetic mutations linked to infertility

More information

Igenomix está na mídia

A IGENOMIX não patrocinou nenhuma notícia ou publicação identificada acima. A cobertura de notícias não constitui um endosso da IGENOMIX ou dos seus produtos

NÓS TE GUIAMOS

Fertilidade
Prevenção de doenças hereditárias
Gravidez saudável

TODOS OS SERVIÇOS

Genética Reprodutiva
Diagnóstico de Doenças Genéticas

SOBRE NÓS

Sobre a Igenomix
Laboratórios
Notícias
Qualidade
Trabalhe conosco
Como enviar uma amostra?

gestão de resíduos

SIGA-NOS

Blog: Caminho da Fertilidade

SELO ONA 2026

⬇️ Clique e confira o Certificado: 385-007-279

Instituição Acreditadora Credenciada Instituto Qualisa de
Gestão - IQG | Validade: 10/2026

Central de Atendimento Brasil: 11 2500 1570 WhatsApp: 11 9 7117 9759  atendimentoaocliente@igenomix.com

  • Brazil
  • Canada
  • Europe
  • India
  • Italy
  • Japan
  • Korea
  • Latam
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
Idioma

Igenomix Brasil Laboratório de Medicina Genética LTDA |
CNPJ 19.555.576/0001-43 | Endereço Av. República do Líbano, 500 - 04502-000 | São Paulo - SP | Responsável Técnica: Paula Regina Queiroz Estrada CRbio 113829/01-D | email: infobrasil@igenomix.com

[2024] © Igenomix Política de qualidade Política de Privacidade  Nota legal Política de cookies Direitos do Paciente

Contato



  • Patient Journey
    • Before Pregnant
    • IVF Process
    • Healthy pregnancy
    • After birth
  • SAÚDE REPRODUTIVA
  • SAÚDE GENÉTICA
  • Sobre nós
  • EVENTOS
  • Blog
  • Brasil
  • PORTAL DE CLÍNICAS
  • Central de Atendimento +55 11 2500 1570 WhatsApp +55 11 9 7117 9759